{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:34:28Z","timestamp":1773916468821,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuro-Oncology"],"published-print":{"date-parts":[[2001,10,1]]},"DOI":"10.1215\/15228517-3-4-229","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T02:28:37Z","timestamp":1133836117000},"page":"229-240","source":"Crossref","is-referenced-by-count":21,"title":["Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction"],"prefix":"10.1093","volume":"3","author":[{"given":"C. D.","family":"Riffkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["Neuro-Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T20:56:13Z","timestamp":1171400173000},"score":1,"resource":{"primary":{"URL":"http:\/\/neuro-oncology.dukejournals.org\/cgi\/doi\/10.1215\/15228517-3-4-229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":0,"aliases":["10.1093\/neuonc\/3.4.229"],"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10,1]]}},"URL":"https:\/\/doi.org\/10.1215\/15228517-3-4-229","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10,1]]}}}